Searched for
DPCO NPPA
Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...- Government caps trade margin on pulse oximeter, nebuliser, digital thermometer at 70 percentThe National Pharmaceuticals Pricing Authority (NPPA) has invoked extraordinary powers under the Paragraph 19 of DPCO, 2013, to put a cap o...
- Violation of drug price control order: Drug cos under NPPA lens for self-exemption from price capPricing watchdog has found that companies such as Lupin and Boehringer Ingelheim launched products bypassing the regulatory framework. The ...
- NPPA revises ceiling prices of 5 scheduled drug formulationsNPPA has been entrusted with the task of fixing and revising prices of pharma products, enforcement of provisions of DPCO and monitoring th...
- NPPA revises rates of 6 drugs, fixes price of 1 medicineIn respect of medicines not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
- NPPA seeks info about pricing, products from stent makersThe National Pharmaceutical Pricing Authority (NPPA) has also called for a meeting with the stakeholders to discuss the issue on January 24.
- Prices of HIV, diabetes and angina drugs slashed by up to 44%The National Drug Pricing Regulator has also fixed the retail prices of 29 formulations.
- NPPA sets ceiling price of 123 drugs in JulyBesides, the National Pharmaceutical Pricing Authority (NPPA) fixed retail prices of 51 medicines in July, taking the cumulative figure for...
- NPPA issues notices to drug companies over violations of DPCO 2013NPPA has issued notices to major drug firms for failing to register products on online database IPDMS and not filing mandatory returns thro...
- Wockhardt, Alembic challenge NPPA's price revision move in Delhi HCThis comes closely after the Mumbai High Court granted an interim order to members of two pharma lobby groups opposing the drug pricing wat...
- Drug price regulator finds 4,700 medicines illegally over-pricedThe national drug price regulator NPPA has warned of action against companies violating its pricing norms as it found prices of more than 4...
- NPPA exempts price controls for three insulins of WockhardtIndia’s drug pricing watchdog, the National Pharmaceutical Pricing Authority (NPPA), has exempt drug maker Wockhardt’s three insulin produc...
- Prices of around 12,000 drug SKUs decline in January: NPPAPrices of around 12,000 stock keeping units (SKUs) of medicines have come down during January this year as a consequence of implementation ...
- Government decision to cap condom prices illegal: Delhi HCDelhi High Court today held as "illegal and unsustainable" the Centre's decision to put a ceiling on the price of condoms, including the lu...
- NPPA seeks details of price movement of certain ortho implantsNPPA has sought details from some medical device companies regarding the price movement of certain orthopaedic implants in last three years.
- Decontrolling prices of cardiac, diabetes drugs challenged in SCUnder Drug Price Control Order 2013, the government already controls the prices of 348 drugs listed in the National List of Essential Medic...
- NPPA asks drug makers to register for online databaseNational drug pricing regulator NPPA has asked all pharmaceutical firm to register themselves under the IPDMS for online filing of returns.
- Prices of 108 diabetes, cardiac formulations fixed: NPPAThe drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others.
- State Drug Authorities can seek data from pharma cosUnder the proposed new Drug Price Control Order 2002, drug Controllers at the state level would be authorised to collect data from pharmace...
- NPPA to submit recommendations by end of the weekNational Pharmaceutical Pricing Authority (NPPA) will submit its recommendations on the Drug Price Control Order (DPCO) 2002, based on the ...
Load More
